During Tuesday’s trading session, the shares of the second largest pharmacy retailer in India surged 3.3 percent to Rs. 742.9 on BSE, after Morgan Stanley and other DIIs bought shares worth a total of around Rs. 552.55 crores in the company via a block deal on NSE.
With a market capitalisation of Rs. 8,864.4 crores, at 11:20 a.m., the shares of Medplus Health Services Limited were trading in the green at Rs. 741.5, up by nearly 3.1 percent, as compared to its previous closing price of Rs. 719.2.
What’s the News:
As per the latest block deal available with the NSE, Morgan Stanley Asia Singapore PTE bought nearly 1.42 lakh equity shares in Medplus Health Services through an open market transaction for about Rs. 10 crores, at an average price of Rs. 700 per share.
Further, Franklin Templeton Mutual Fund purchased a 1.3% stake, Invesco Mutual Fund acquired a 2.6% stake, and Kotak Mahindra Mutual Fund also bought a 2.6% stake, collectively purchased about 77.5 lakh equity shares in the company at an average price of Rs. 700 per share. The total value of these transactions reached approximately Rs. 542.55 crore.
However, on the seller side, PI Opportunities Fund exited the company by selling its entire 5.77% stake, while SBI Mutual Fund offloaded the 10 lakh shares at the same average price.
Financials:
The company reported a marginal growth in consolidated revenue from operations, experiencing a year-on-year increase of nearly 12 percent, rising from Rs. 1,409 crores in Q2 FY24 to Rs. 1,576 crores in Q2 FY25.
Likewise, during the same period, the company’s net profit increased from Rs. 15 crores to Rs. 39 crores, representing a significant growth of around 160 percent YoY.
The operating EBITDA for Q2 FY25 reached Rs. 73.8 crores, representing an increase of around 80.2 percent YoY from Rs. 401 crores in Q2 FY24, with an operating EBITDA Margin of 4.7 percent, up from 2.9 percent, during the same period.
Also read…
Stock Performance
The shares of MedPlus Health Services have delivered negative returns of nearly 11.4 percent of returns in one year, while around 5.2 percent of positive returns in the last six months.
About the Company:
MedPlus Health Services Limited is primarily engaged in the business of provision of diagnostic services, pathological services and laboratory testing services. Further, the company is also engaged in the manufacturing, purchase and sale of pharmaceuticals and other general items and rendering of management services to group companies.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
